Celea Therapeutics
Develops treatments for serious respiratory diseases
$180MGrowth
Role not disclosedLoading investors…
Activity from announced rounds
Develops treatments for serious respiratory diseases
Develops ultrasound-mediated nonviral genetic medicines
Pitching Leaps by Bayer? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room